BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10937286)

  • 1. Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes.
    Katahira N; Murakami T; Kugai S; Yata N; Takano M
    J Drug Target; 1999; 6(6):405-14. PubMed ID: 10937286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
    Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
    Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
    Manconi M; Sinico C; Valenti D; Lai F; Fadda AM
    Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.
    Hathout RM; Mansour S; Mortada ND; Guinedi AS
    AAPS PharmSciTech; 2007 Jan; 8(1):1. PubMed ID: 17408209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of liposome on permeability and drug retention of sodium fluorescein in rat skin: an experimental study].
    Xie YS; Zeng K; Li GF; Dong P; Shi YM; Zhu XL; Sun LD; Hou GR
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):110-3. PubMed ID: 12581954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction.
    Sinico C; Manconi M; Peppi M; Lai F; Valenti D; Fadda AM
    J Control Release; 2005 Mar; 103(1):123-36. PubMed ID: 15710506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis.
    Han I; Kim M; Kim J
    Exp Dermatol; 2004 Feb; 13(2):86-92. PubMed ID: 15009101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles.
    Puglia C; Esposito E; Menegatti E; Nastruzzi C; Rizza L; Cortesi R; Bonina F
    J Pharm Pharmacol; 2005 Sep; 57(9):1169-76. PubMed ID: 16105237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical liposome system bearing local anaesthetic lignocaine: preparation and evaluation.
    Sharma BB; Jain SK; Vyas SP
    J Microencapsul; 1994; 11(3):279-86. PubMed ID: 8064552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
    Tabbakhian M; Tavakoli N; Jaafari MR; Daneshamouz S
    Int J Pharm; 2006 Oct; 323(1-2):1-10. PubMed ID: 16837150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ; Fidler IJ
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enhancement of immunosuppressive effects of cyclosporine A on human T-cells using fusogenic liposomes.
    Malaekeh-Nikouei B; Jaafari MR; Tabassi SA; Samiei A
    Colloids Surf B Biointerfaces; 2008 Dec; 67(2):238-44. PubMed ID: 18930640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies.
    Manconia M; Pendás J; Ledón N; Moreira T; Sinico C; Saso L; Fadda AM
    J Pharm Pharmacol; 2009 Apr; 61(4):423-30. PubMed ID: 19298687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state.
    Barichello JM; Handa H; Kisyuku M; Shibata T; Ishida T; Kiwada H
    J Control Release; 2006 Sep; 115(1):94-102. PubMed ID: 16919352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes in topical drug delivery.
    Schaeffer HE; Krohn DL
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):220-7. PubMed ID: 7056633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment.
    Srisuk P; Thongnopnua P; Raktanonchai U; Kanokpanont S
    Int J Pharm; 2012 May; 427(2):426-34. PubMed ID: 22310459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparation of liposomal formulations of ALA Undecanoyl ester for its use in photodynamic therapy.
    Di Venosa G; Hermida L; Fukuda H; Defain MV; Rodriguez L; Mamone L; MacRobert A; Casas A; Batlle A
    J Photochem Photobiol B; 2009 Aug; 96(2):152-8. PubMed ID: 19560367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.